百晓学者学者目录

徐云根

副研究员、助理研究员、教授、研究员,中国药科大学

精选作品

期刊论文

2026

新型PARP7抑制剂的设计、合成与生物活性研究

袁浩,汪勇,严文昕,李珠旺,徐云根,古宏峰

《中国药物化学杂志》

2026

Discovery of Oxime Ether Derivatives as Second-Generation PRMT5 Inhibitors for the Treatment of Triple Negative Breast Cancer.

Xing-Xing Cheng, Zheqi Hu, Huihuan Mao, Zi-Yue Li, Zhen Wang, Y. Tang, Shi-Hui Huang, Yujing Huang, Chunxiang Yin, Han-Xi Xing, Sijia Chen, Yuhan Jiang, Ting Hu, J. Zuo, Wenxin Yan, Hongfeng Gu, Ping Wei, Yun-Gen Xu, Qi-Hua Zhu, Yi Zou

Journal of Medicinal Chemistry

2026

Discovery of Highly Potent Phthalazinone Derivatives as PARP14 Inhibitors: From Structure-Based Virtual Screening to In Vivo Pharmacodynamic Activity.

Shi-Qi Wu, Kaiyuan Cong, Jing Liu, Le Qu, Xiaorong Zeng, Xiangying Kong, Zi-Yue Li, Shaoxue Lou, Ping Wei, Li Shao, Hongfeng Gu, Yan Zhao, Qin-Long Xu, Zhao-Xing Chu, Guang-Wei He, Qi-Hua Zhu, Yun-Gen Xu, Yi Zou

Journal of Medicinal Chemistry

2026

Discovery of Novel Orally Bioavailable Polθ Inhibitors with Arylalkyne Scaffolds for Targeting HR-Deficient Cancers.

Jinyang Zhang, Xiaomeng Sun, Qi-Chen Zhou, Ying Wei, Biao Chen, Jun-Hui Jiao, Yu Du, Shepherd Wufoyrwoth, Haoze Chi, Y. Yang, Ping Wei, Yun-Gen Xu, Yi Zou, Qi-Hua Zhu

Journal of Medicinal Chemistry

2026

Correction to "Discovery of Hydroxamic Acid Ester Derivatives as Second-Generation PRMT5 Inhibitors for the Treatment of Triple Negative Breast Cancer".

Xing-Xing Cheng, Zheqi Hu, Huihuan Mao, Zi-Yue Li, Zhen Wang, Y. Tang, Shihui Huang, Yujing Huang, Chunxiang Yin, Han-Xi Xing, Sijia Chen, Yuhan Jiang, T. Hu, J. Zuo, Wenxin Yan, Hongfeng Gu, Ping Wei, Yun-Gen Xu, Qi-Hua Zhu, Yi-Ren Zou

Journal of Medicinal Chemistry

2026

Identification of an Orally Bioavailable Quinoline-Based Small-Molecule Tumor Necrosis Factor α (TNF-α) Inhibitor Featuring a Spirocyclic Scaffold.

Zeren Sun, Wen-Bin Zhang, Wan-Yong He, Jie Xu, Boning Wang, Joshua M. He, Yu-Chen Zhang, Pu Chen, Yao Luo, Jia-Ning Gu, Hongfeng Gu, Ping Wei, Ya-Nan Sun, Chunxiang Yin, Han-Xi Xing, Yan-Nan Luo, Jing-Jing Zhang, Qi-Hua Zhu, Yi Zou, Yun-Gen Xu

Journal of Medicinal Chemistry

2026

Discovery of Novel and Potent Dual PARP1/ERK Inhibitors as a Promising Strategy for Cancer Therapy.

Ying Bai, Shi-Qi Wu, Wenhui Zhang, Yuepeng Chen, Wenxin Yan, Lei-ming Huang, Jing Liu, Zhaohui Guan, Yupei Su, Dongqing Guo, Yuchen Bian, Kaiyuan Cong, Yi Zou, Haiping Hao, Qi-Hua Zhu, Hong Wang, Yun-Gen Xu

Journal of Medicinal Chemistry

2026

In vitro and ex vivo Pharmacological Profile of HY-022619, a Novel Intravenous P2Y12 Receptor Antagonist with Rapid-onset and Sustained Antiplatelet Activity

Jia-Jia Mo, Emily M. He, Yan Zhao, Li Shao, Shaoyun Yue, Yanmei Xie, Shi-Qi Wu, Jianxun He, Yi Zou, Zhao-Xing Chu, Guang-Wei He, Yun-Gen Xu

Pharmaceutical Research

2026

ChalcoVina: Enhancing Molecular Docking Accuracy by Incorporating Chalcogen Bond-Aware Scoring

Wen-Hao Cai, Zi-Yue Li, Yi-Jie Wang, Wei-Tian Yu, Yu Sun, Yun-Gen Xu, Qi-Hua Zhu, Yi Zou

Journal of Chemical Information and Modeling

2026

Development of a Scalable Synthetic Route and a Crystal Morphology Characterization Method for the PDE4B Inhibitor HY-072808

Jianxun He, Dong Zuo, Jun Tang, Zhen Wang, Bo Wang, Bing Liu, Qiang Zhang, Guang-Wei He, Yun-Gen Xu

Organic Process Research & Development

2026

Blood-Brain Barrier-Permeable siRNA Nanodrugs With Dual-Gene Knockdown for Alzheimer's Disease Therapy.

Feng Su, Sheng Lu, Yao-Yao Zhang, Yu Zhang, Lingxuan Cheng, Jing Li, Jun-Lin Zhang, Ying Li, Yun-Gen Xu, Guang-Wei He, Lifang Yin

Clinical and Experimental Pharmacology and Physiology

2025

第二代蛋白精氨酸甲基转移酶5抑制剂的研究进展

胡浙棋,尹春香,毛慧欢,常艺清,朱启华,徐云根,龚国清,邹毅

《中国药科大学学报》

2025

靶向下丘脑-垂体-肾上腺轴的抗抑郁药物研究进展

黄钰婧,王茹,徐云根

《药学进展》

2025

异吲哚啉酮类ERK抑制剂的设计、合成及初步生物活性研究

张灵芝,鞠秋荣,管哲,朱启华,张婷婷,杨诗勤,徐云根

《高等学校化学学报》

2025

基于QbD理念的药物合成工艺课程教学方法探讨

古宏峰,朱启华,徐云根

《药学教育》

2025

Discovery and Optimization of Potent and Highly Selective PARP14 Inhibitors for the Treatment of Atopic Dermatitis.

Shi-Qi Wu, Xiaorong Zeng, Jing Liu, Kaiyuan Cong, S. Lou, Zi-Yue Li, Ping Wei, Li Shao, Yao-Yao Zhang, Le Qu, Ti-Zhi Wu, Hongfeng Gu, Yan Zhao, Zhao-Xing Chu, Qi-Hua Zhu, Guang-Wei He, Yi Zou, Yun-Gen Xu

Journal of Medicinal Chemistry

2025

Discovery and Optimization of Novel Apo-IDO1 Inhibitors by a Pharmacophore-Based Structural Simplification Strategy.

Lifang Cen, Yunze Wu, Mingchao He, Jingling Huang, Weijie Ren, Beibei Liu, Liu-Qiong Meng, Lei-ming Huang, Hongfeng Gu, Yun-Gen Xu, Qi-Hua Zhu, Yi Zou

Journal of Medicinal Chemistry

2025

Discovery of Novel and Highly Potent Wee1 and HDAC Dual-Target Inhibitors for the Treatment of Acute Myeloid Leukemia.

Wenhui Zhang, Wenxin Yan, Tianyi Wei, Sai Che, Yangqian Sun, Aohua Xiao, Jia-Yu Wu, Yunzhen Zhan, Hongmei Li, Tao Lu, Yun-Gen Xu, Hongfeng Gu, Hui Huang, Jinsong Han

Journal of Medicinal Chemistry

2025

PARP7: an Emerging Therapeutic Target-Insights into Biological Functions and Advances in Small-Molecule Inhibitor Development.

Feihuang Qiu, Jianqiao Wang, Ke-Han Huang, Tianxiang Shang, Chenghao Wang, Wenxin Yan, Yun-Gen Xu, Hongfeng Gu

Journal of Medicinal Chemistry

2025

Discovery of novel JAK3 inhibitors for the treatment of atopic dermatitis.

Weijie Ren, Lifang Cen, Xin-Yue Li, Jia-Jie Yu, Shi-Qi Wu, Jing Liu, Lu-Hua Wang, Xiangying Kong, Yi Zou, Yun-Gen Xu

Bioorganic & Medicinal Chemistry Letters

2025

MDM2 Degrader as a Promising Therapeutic Strategy for Cancer Treatment.

Shi-Qi Wu, Yun-Gen Xu

Journal of Medicinal Chemistry

2025

Discovery of Orally Potent Small-Molecule CD73 Inhibitor for Cancer Immunotherapy.

Lifang Cen, Weijie Ren, Jia-Jie Yu, M. Cheng, Xiangying Kong, Wenxin Yan, Lu-Hua Wang, Xin-Yue Li, Jing Liu, Zhen Wang, Shi-Qi Wu, Xiaomeng Sun, Ping Wei, Hongfeng Gu, Qi-Hua Zhu, Yi Zou, Yun-Gen Xu

Journal of Medicinal Chemistry

2025

Discovery of PKMYT1 Inhibitors with a Novel Scaffold for the Treatment of Triple-Negative Breast Cancer.

Jingling Huang, Peixuan Li, Feihuang Qiu, Ying Fu, Wenxin Yan, Yong-Ling Xu, Xinyu Sun, Xiu-Hua Zhang, Yi Zou, Qi-Hua Zhu, Yun-Gen Xu, Hongfeng Gu

Journal of Medicinal Chemistry

2025

Characterization of Protein-Ligand Chalcogen Bonds: Insights from Database Survey and Quantum Mechanics Calculations

Wen-Hao Cai, Zi-Yue Li, Wang Zhou, Honglin Chen, Yun-Gen Xu, Qi-Hua Zhu, Yi Zou

Journal of Chemical Information and Modeling

2025

Discovery of a spirocyclic influenza RNA-dependent RNA polymerase inhibitor.

Jianxun He, Zhao-Xing Chu, Qin-Long Xu, Yi Zou, Gaofeng Lin, Jia-Jia Mo, Li Shao, Yan Zhao, Jiaming Li, Wen-Feng Ye, Tao Fang, Qi-Hua Zhu, Guang-Wei He, Yun-Gen Xu

Bioorganic chemistry (Print)

2025

Parps in immune response: Potential targets for cancer immunotherapy.

Shu-Ping Wang, Jingling Huang, Ting-Yu Zeng, Ya-Li Chen, Yun-Gen Xu, Bangzhi Zhang

Biochemical Pharmacology

2025

Discovery of a novel benzofuran-7-carboxamide-based PARP1/c-Met dual inhibitor for addressing c-Met amplification-mediated PARP1i acquired-resistance.

Zeren Sun, Mengxuan Hu, Jie Xu, Bingxin Zhai, Yu-Chen Zhang, Wen-Bin Zhang, Boning Wang, Runyuan Wang, Zheqi Hu, Yun-Gen Xu, Qi-Hua Zhu, Yi Zou

European journal of medicinal chemistry

2024

基于免疫调控的药物研发进展

徐云根

《中国药科大学学报》

2024

人工智能技术在先导化合物发现与优化中的应用进展

李紫玥,丛开源,吴诗琪,朱启华,徐云根,邹毅

《药学学报》

2024

BTK/JAK3双靶点抑制剂的设计合成和生物活性评价

岑丽芳,程铭,任玮杰,叶柳,王禄华,郭维博,张强,徐云根

《中国药科大学学报》

2024

肿瘤免疫治疗靶点CD73及其抑制剂研究进展

王文泽,陈跃鹏,岑丽芳,邹毅,徐云根

《中国现代应用药学》

2024

Rational Design of PARP1/c-Met Dual Inhibitors for Overcoming PARP1 Inhibitor Resistance Induced by c-Met Overexpression.

Zeren Sun, Lanjie Li, Bingxin Zhai, Mengxuan Hu, Lei-ming Huang, Shi-Hui Huang, L. Ye, Xiangying Kong, Jie Xu, J. Bai, Jingjie Yan, Qi-Chen Zhou, Zheqi Hu, Yu-Chen Zhang, Yu-Han Jiang, Yan Zhang, Zhou Qiao, Yi Zou, Yun-Gen Xu, Qi-Hua Zhu

Journal of Medicinal Chemistry

2024

Discovery of Highly Potent Small-Molecule PD-1/PD-L1 Inhibitors with a Novel Scaffold for Cancer Immunotherapy.

Yong-Ling Xu, Huijie Du, Wei Guo, Beibei Liu, Wenxin Yan, Chi Zhang, Long Qin, Jingling Huang, Hongxia Wang, Shi-Qi Wu, Weijie Ren, Yi Zou, Jie Wang, Qi-Hua Zhu, Yun-Gen Xu, Hongfeng Gu

Journal of Medicinal Chemistry

2024

Discovery of the novel and potent histamine H1 receptor antagonists for treatment of allergic diseases.

Zhao-Xing Chu, Lifang Cen, Qin-Long Xu, Gaofeng Lin, Jia-Jia Mo, Li Shao, Yan Zhao, Jiaming Li, Wen-Feng Ye, Tao Fang, Weijie Ren, Qi-Hua Zhu, Guang-Wei He, Yun-Gen Xu

European journal of medicinal chemistry

2024

Discovery of novel EGFR-PROTACs capable of degradation of multiple EGFR-mutated proteins.

Yu Du, Shi Shi, Chengxia Shu, Ye-Zi He, Wangyang Xu, Daochen Wu, Yushu Tian, Mingyang Kong, Jia-Huan He, W. Xie, Yijia Qiu, Yun-Gen Xu, Yi Zou, Qi-Hua Zhu

European journal of medicinal chemistry

2024

Discovery of the first ataxia telangiectasia and Rad3-related (ATR) degraders for cancer treatment.

Lei-ming Huang, Jialu Shao, Wenwen Lai, Hongfeng Gu, Jieping Yang, Shi Shi, Shepherd Wufoyrwoth, Zhe Song, Yi Zou, Yun-Gen Xu, Qi-Hua Zhu

European journal of medicinal chemistry

2024

Design, synthesis, and antitumor activity evaluation of 1,2,3-triazole derivatives as potent PD-1/PD-L1 inhibitors.

Yu Xia, Hong-Bo Zhang, Huijie Du, Lei Huang, Chunqiu Yu, Hao Wu, Yiwei Zhang, Yun-Gen Xu, Qi-Hua Zhu, Yi Zou

Bioorganic chemistry (Print)

2024

Discovery of highly potent PARP7 inhibitors for cancer immunotherapy.

Jieping Yang, Beibei Liu, Wenxin Yan, Xiaolin Zhao, Chenghao Wang, Qi-Hua Zhu, Yi Zou, Yun-Gen Xu, Hongfeng Gu

Bioorganic chemistry (Print)

2024

New TIPARP inhibitor rescues mitochondrial function and brain injury in ischemic stroke.

Yang Cai, Hongfeng Gu, Lu Li, Xueyu Liu, Ying Bai, Ling Shen, Bing Han, Yun-Gen Xu, Honghong Yao

Pharmacological Research

2023

药物化学

徐云根

2023

在药物化学实验教学中培养学生的科研思维

钟毅,徐云根

《药学教育》

2023

PARP-1/PI3K双靶点抑制剂的设计、合成与生物活性

黄至诚,叶柳,杜宇,古宏峰,高凡云,朱启华,徐云根

《中国药科大学学报》

2023

新型1,2,3-三氮唑类衍生物的合成及抗炎活性研究

孙泽人,翟冰新,何光超,沈慧,陈琳雅,张杉,邹毅,朱启华,徐云根

《有机化学》

2023

Discovery of Highly Selective PARP7 Inhibitors with a Novel Scaffold for Cancer Immunotherapy.

Hongfeng Gu, Wenxin Yan, Jieping Yang, Beibei Liu, Xiaolin Zhao, Hongxia Wang, Wen-Bo Xu, Chenghao Wang, Yang Chen, Qi Dong, Qi-Hua Zhu, Yun-Gen Xu, Yi Zou

Journal of Medicinal Chemistry

2023

Discovery of novel dual Bruton's tyrosine kinase (BTK) and Janus kinase 3 (JAK3) inhibitors as a promising strategy for rheumatoid arthritis.

Tingting Liang, Lifang Cen, Junjie Wang, Ming-Fu Cheng, Weibo Guo, Wen-Jie Wang, Chunqiu Yu, Haifeng Zhang, Yuan Wang, Zhongyan Hao, Jiaming Jin, Yaoyao Wu, Teng Jiang, Qi-Hua Zhu, Yun-Gen Xu

Bioorganic & Medicinal Chemistry

2023

DCLK1 and its oncogenic functions: A promising therapeutic target for cancers.

Liu Ye, Beibei Liu, Jingling Huang, Xiaolin Zhao, Yuan Wang, Yun-Gen Xu, Shu-Ping Wang

Life Science

2023

An overview of limonoid synthetic derivatives as promising bioactive molecules.

Shao-Chi Wang, Laura L. Kuperman, Zhihui Song, Yutian Chen, Kun Liu, Z. Xia, Yun-Gen Xu, Qiu-Ning Yu

European journal of medicinal chemistry

2023

Synthesis and Anti-inflammatory Evaluation of Novel 1,2,3-Triazole Derivatives

Zeren Sun, Bingxin Zhai, Guangchao He, Hui Shen, Lin Chen, Shan Zhang, Yi Zou, Qi-Hua Zhu, Yun-Gen Xu

Youji huaxue

2022

SHP2小分子抑制剂研究进展及构效关系分析

关兆辉,徐学宇,唐海,徐云根

《药学进展》

2022

蛋白质精氨酸甲基转移酶5小分子抑制剂的研究进展

李慧,邹毅,宋利,唐海,徐云根

《中国药学杂志》

2022

工具性导向的化学生物学课程教学探索

王淑平,褚钱,孙丽萍,姚和权,徐云根

《药学教育》

2022

棕榈酸曲安奈德中未知杂质的鉴定(英文)

金祥飞,程闽玥,钟斯卉,徐云根,沈卫阳

Journal of Chinese Pharmaceutical Sciences

2022

Discovery of the Potent and Highly Selective PARP7 Inhibitor as a Novel Immunotherapeutic Agent for Tumors.

H. Gu, Wenxin Yan, Yong Wang, Wenbo Xu, Lei-ming Huang, Jieping Yang, Bingxin Zhai, Hong Wang, Yupei Su, Qi-Hua Zhu, Beibei Liu, H. Hao, Yi Zou, Yun-Gen Xu

Journal of Medicinal Chemistry

2022

Rational Design for Nitroreductase (NTR)-Responsive Proteolysis Targeting Chimeras (PROTACs) Selectively Targeting Tumor Tissues.

S. Shi, Y. Du, Yi Zou, Jing Niu, Ze-Yu Cai, Xiaonan Wang, Fei-Hua Qiu, Yi Ding, G. Yang, Yunze Wu, Yun-Gen Xu, Qi-Hua Zhu

Journal of Medicinal Chemistry

2022

Design, synthesis and biological evaluation of novel 4-aminopiperidine derivatives as SMO/ERK dual inhibitors.

Jing-jing Zhang, Wanwan Zhang, Lei Zhang, Meng-Xuan Hu, Qi-jie Xu, Yun-Gen Xu

Bioorganic & Medicinal Chemistry

2022

Design, synthesis and antitumor activity study of PARP-1/HDAC dual targeting inhibitors.

Ziwei Chi, Ying Bai, Jing Li, Ke-Wei Wang, Yun-Gen Xu, Y. Luan

Bioorganic & Medicinal Chemistry Letters

2022

Discovery of the First Selective IDO2 Inhibitor As Novel Immunotherapeutic Avenues for Rheumatoid Arthritis.

Guangchao He, Sheng Wan, Yunze Wu, Zhao-Xing Chu, Hui Shen, Shan Zhang, Lin Chen, Zi-Jing Bao, Shuhui Gu, Jun-Jian Huang, Lei-ming Huang, Guoqing Gong, Yi Zou, Qi-Hua Zhu, Yun-Gen Xu

Journal of Medicinal Chemistry

2022

Rh(III)-Catalyzed C-H Activation and [4+1+1] Sequential Cyclization Cascade to Give Highly Fused Indano[1,2-b]azirines.

Fuqiang Zheng, Jianhui Zhou, Feifei Fang, Ji-Yuan Li, Jing Wang, Miao Zheng, Hong Liu, Yun-Gen Xu, Yu Zhou

Organic Letters

2022

Preclinical Drug Pharmacokinetic, Tissue Distribution and Excretion Profiles of the Novel Limonin Derivate HY-071085 as an Anti-Inflammatory and Analgesic Candidate in Rats and Beagle Dogs

Liping Dong, Wenjuan Liu, Xiaoyuan Zhao, Feng Yu, Yun-Gen Xu, Meng-Xiang Su

Pharmaceuticals

2022

Design, Synthesis and Biological Evaluation of Novel and Potent Protein Arginine Methyltransferases 5 Inhibitors for Cancer Therapy

Yixuan Tang, Shi-Hui Huang, X. Chen, Jun-Jian Huang, Qianwen Lin, Lei-ming Huang, Shu-Ping Wang, Qi-Hua Zhu, Yun-Gen Xu, Yi Zou

Molecules

2022

Discovery of novel potent covalent inhibitor-based EGFR degrader with excellent in vivo efficacy.

Shi-Hui Shi, Yuan Du, Lei Huang, Jianwei Cui, Jing Niu, Yun-Gen Xu, Qi-Hua Zhu

Bioorganic chemistry (Print)

2022

Anti-inflammatory Effect of a Limonin Derivative In Vivo and Its Mechanisms in RAW264.7 Cells

Ning Wang, Xiao Chen, Yingying Ji, Tian Lan, Wei Yan, Yun-Gen Xu, Guoqing Gong

Inflammation

2022

Dual‐target synergistic antithrombotic mechanism of a dabigatran etexilate analogue (HY023016)

Sheng Wan, Shuang Cui, Minrui Jiang, Qian Wu, Yingying Ji, Yun-Gen Xu, Guoqing Gong

Clinical and Experimental Pharmacology and Physiology

2022

Discovery of novel Thieno[2,3-d]imidazole derivatives as agonists of human STING for antitumor immunotherapy using systemic administration.

Jing Niu, Hudagula Bai, Zizhou Li, Yu-Zhe Gao, Yan Zhang, Xiyuan Wang, Yaxi Yang, Yun-Gen Xu, M. Geng, Zuoquan Xie, Bing Zhou

European journal of medicinal chemistry

2021

单-ADP核糖转移酶家族及其抑制剂在肿瘤治疗中的研究进展

李茵,古宏峰,邹毅,王淑平,徐云根

《中国药科大学学报》

2021

Discovery of Potent and Novel Dual PARP/BRD4 Inhibitors for Efficient Treatment of Pancreatic Cancer.

Shu-Ping Wang, Yu Li, Shi-Hui Huang, Shi-Qi Wu, Ling Gao, Qin Sun, Qian-Wen Lin, Lei-ming Huang, Liu-Qiong Meng, Yi Zou, Qi-Hua Zhu, Yun-Gen Xu

Journal of Medicinal Chemistry

2021

Discovery of the First Potent IDO1/IDO2 Dual Inhibitors: A Promising Strategy for Cancer Immunotherapy.

Xin He, Guangchao He, Zhao-Xing Chu, Huanhuan Wu, Junjie Wang, Yiran Ge, Hui Shen, Shan Zhang, Jin-Jun Shan, Kewen Peng, Zhifeng Wei, Yi Zou, Yun-Gen Xu, Qi-Hua Zhu

Journal of Medicinal Chemistry

2021

Design, synthesis and biological evaluation of novel molecules as potent PARP-1 inhibitors.

Hui Shen, Yiran Ge, Jun-Wei Wang, Hui Li, Yun-Gen Xu, Qi-Hua Zhu

Bioorganic & Medicinal Chemistry Letters

2021

Discovery of novel IDO1 inhibitors targeting the protein's apo form through scaffold hopping from holo-IDO1 inhibitor.

Yunze Wu, Q. Duan, Yi Zou, Qi-Hua Zhu, Yun-Gen Xu

Bioorganic & Medicinal Chemistry Letters

2021

Structure-activity relationships and antiproliferative effects of 1,2,3,4-4H-quinoxaline derivatives as tubulin polymerization inhibitors.

T. Liang, Xiaomin Zhou, Lu Lu, Haiyang Dong, Ya-Nan Zhang, Yun-Gen Xu, Jianguo Qi, Yahong Zhang, Jianhong Wang

Bioorganic chemistry (Print)

2021

Design, synthesis and biological evaluation of novel benzoxaborole derivatives as potent PDE4 inhibitors for topical treatment of atopic dermatitis.

Zhao-Xing Chu, Qin-Long Xu, Qi-Hua Zhu, Xiao-Dong Ma, Jia-Jia Mo, Gao-Feng Lin, Yan Zhao, Y. Gu, Li-Na Bian, Li Shao, Jing Guo, Wenfeng Ye, Jiaming Li, Guang-Wei He, Yun-Gen Xu

European journal of medicinal chemistry

2021

Discovery of novel and potent PARP/PI3K dual inhibitors for the treatment of cancer.

Zhengyang Wu, Ying Bai, Jia-Qi Jin, Teng Jiang, Hui Shen, Q. Ju, Qi-Hua Zhu, Yun-Gen Xu

European journal of medicinal chemistry

2021

Discovery of Novel Small-Molecule Inhibitors of PD-1/PD-L1 Interaction via Structural Simplification Strategy

Hong-Bo Zhang, Yuhui Xia, Chunqiu Yu, Huijie Du, Jinchang Liu, Hui Li, Shi-Hui Huang, Qi-Hua Zhu, Yun-Gen Xu, Yi Zou

Molecules

2021

Curcumin Complex Analogues as Near-Infrared Fluorescent Probes for Monitoring all Aβ Species in the Early Alzheimer's Disease Model.

Yiran Ge, Fan-Tian Zeng, Gaofeng Sun, Kewen Peng, Xiao Li, Huijuan Yu, Chao Cheng, Yun-Gen Xu, Jian Yang

ACS Chemical Neuroscience

2020

1-(取代)苯磺酰基-3-烷胺基甲基吲哚衍生物的设计合成及其抑酸活性研究

何光超,黄群刚,储昭兴,梁停停,王俊杰,朱启华,徐云根

《中国药物化学杂志》

2020

小分子ERK抑制剂的研究进展

梁停停,王文杰,郝思远,何光超,徐云根

《中国药科大学学报》

2020

BET溴结构域抑制剂的研究进展

曹冉,李煜,朱启华,徐云根

《中国药物化学杂志》

2020

以培养自主学习能力为目标的药学工作坊建设

李玉艳,姜正羽,孙丽萍,徐云根

《药学教育》

2020

依伐卡托中间体的合成工艺改进

梁停停,王均伟,朱启华,徐云根

《化学试剂》

2020

抗丙肝新药盐酸氘代达卡他韦的合成

丰巍伟,刘飞,徐云根,张寅生

《中国医药工业杂志》

2020

含有黄嘌呤衍生物的N-杂环卡宾金属配合物的生物活性研究进展

王致斌,于春秋,张婉婉,张晶晶,徐云根

《药学进展》

2020

Smoothened抑制剂的耐药机制及克服耐药性的策略研究

张婉婉,张磊,徐云根,张晶晶

《药学进展》

2020

N-(三氘代甲氧羰基)-L-缬氨酸的合成

丰巍伟,刘飞,徐云根,朱雪焱,张寅生

《药学与临床研究》

2020

Design, synthesis and biological evaluation of N-hydroxy-aminobenzyloxyarylamide analogues as novel selective κ opioid receptor antagonists.

Guangchao He, Qiao Song, Jun-Wei Wang, Anhua Xu, Kewen Peng, Qi-Hua Zhu, Yun-Gen Xu

Bioorganic & Medicinal Chemistry Letters

2020

Design, synthesis and biological evaluation of anthranilamide derivatives as potent SMO inhibitors.

De-Zhong Ji, Wanwan Zhang, Yun-Gen Xu, Jing-Jing Zhang

Bioorganic & Medicinal Chemistry

2020

Versatile near-infrared fluorescent probe for in vivo detection of Aβ oligomers.

Fan-Tian Zeng, Jian Yang, Xiao-Fang Li, Kewen Peng, Chong-Zhao Ran, Yun-Gen Xu, Yu-Yan Li

Bioorganic & Medicinal Chemistry

2020

Platinum-based combination therapy: molecular rationale, current clinical uses, and future perspectives.

Chunqiu Yu, Zhibin Wang, Zeren Sun, Lei Zhang, Wanwan Zhang, Yun-Gen Xu, Jing-Jing Zhang

Journal of Medicinal Chemistry

2020

Discovery of Novel Dual Extracellular Regulated Protein Kinases (ERK) and Phosphoinositide 3-Kinase (PI3K) Inhibitors as a Promising Strategy for Cancer Therapy

Ling-Zhi Zhang, Q. Ju, Jin-Jin Sun, Lei-ming Huang, Shi-Qi Wu, Shu-Ping Wang, Yin Li, Zhe Guan, Qi-Hua Zhu, Yun-Gen Xu

Molecules

2020

Synthesis of Limonin Derivatives with Improved Anti-inflammatory and Analgesic Properties

Cheng-Shu Jia, Bin Hu, Yingying Ji, Yourui Su, Guoqing Gong, Qi-Hua Zhu, Yun-Gen Xu

2020

PARP14 inhibits microglial activation via LPAR5 to promote post-stroke functional recovery

Ying Tang, Jinchang Liu, Yu Wang, Li Yang, Bing Han, Yuan Zhang, Ying Bai, Ling Shen, Ming-Yue Li, Teng Jiang, Qing-Qing Ye, Xiaoyu Yu, Rong-Rong Huang, Zhao Zhang, Yun-Gen Xu, Hong-Hong Yao

Autophagy

2020

Discovery of novel PARP/PI3K dual inhibitors with high efficiency against BRCA-proficient triple negative breast cancer.

Jun-Wei Wang, Guangchao He, Hui Li, Yiran Ge, Shu-Ping Wang, Yun-Gen Xu, Qi-Hua Zhu

European journal of medicinal chemistry

2020

Strategies targeting soluble β-Amyloid oligomers and their application to early diagnosis of Alzheimer's Disease.

Fan-Tian Zeng, Yu-Yan Li, Yun-Gen Xu, Jian Yang, Zheng-Shi Liu, Xiao-Fang Li, Long-Fei Ren

Current Alzheimer Research

2020

A practical synthesis of amino limonin/deoxylimonin derivatives as effective mitigators against inflammation and nociception.

Shao-Chi Wang, Xue-Qing Han, Yung-Hsiung Yang, R. Chen, Zhaoyi Guo, Qi-Hua Zhu, Yun-Gen Xu

RSC Medicinal Chemistry

2020

Discovery of deoxylimonin δ-lactam derivative with favorable anti-inflammation and antinociception efficacy from chemical modified limonin/deoxylimonin analogs.

Shao-Chi Wang, Xue-Qing Han, Yung-Hsiung Yang, Chen Zhou, D. Luo, Wensong He, Qi-Hua Zhu, Yun-Gen Xu

Bioorganic chemistry (Print)

2019

PARP-1抑制剂与其他药物联用克服耐药性的研究进展

施锦渝,柏英,彭珂文,张文慧,朱启华,徐云根

《中国药科大学学报》

2019

盐酸绿卡色林的工艺研究?

何光超,王均伟,管哲,朱启华,徐云根

《中国现代应用药学》

2019

PI3K&mTOR双重抑制剂Apitolisib的合成工艺改进

吴正阳,金佳明,沈慧,蒋腾,朱启华,徐云根

《广州化工》

2019

Janus激酶及其抑制剂的研究进展

黄昊哲,张吉星,刘佳,徐云根,孙丽萍

《药学进展》

2019

Discovery of novel nonpeptide small-molecule NRP1 antagonists: Virtual screening, molecular simulation and structural modification.

Kewen Peng, Yu Li, Ying Bai, Teng Jiang, Hui-Yong Sun, Qi-Hua Zhu, Yun-Gen Xu

Bioorganic & Medicinal Chemistry

2019

Design, synthesis and biological evaluation of novel desloratadine derivatives with anti-inflammatory and H1 antagonize activities.

Feng Li, Qin-Long Xu, Qi-Hua Zhu, Zhao-Xing Chu, Gao-Feng Lin, Jia-Jia Mo, Yan Zhao, Jiaming Li, Guang-Wei He, Yun-Gen Xu

Bioorganic & Medicinal Chemistry Letters

2019

Discovery of Novel Dual Poly(ADP-ribose)polymerase (PARP) and Phosphoinositide 3-kinase (PI3K) Inhibitors as A Promising Strategy for Cancer Therapy.

Jun-Wei Wang, Hui Li, Guangchao He, Zhao-Xing Chu, Kewen Peng, Yiran Ge, Qi-Hua Zhu, Yun-Gen Xu

Journal of Medicinal Chemistry

2019

Transition Metal-Free C5 Tosyloxylation of 8-Aminoquinolines with Phenyliodine Bistrifluoroacetate and Substituted 1,2-Disulfonyl Hydrazides

Tingting Liang, Xin He, De-Zhong Ji, Huanhuan Wu, Yizhu Xu, Yu-Yan Li, Zhibin Wang, Yun-Gen Xu, Qi-Hua Zhu

Annalen der Pharmacie

2019

Discovery of potent, orally bioavailable ERK1/2 inhibitors with isoindolin-1-one structure by structure-based drug design.

De-Zhong Ji, Ling-Zhi Zhang, Qi-Hua Zhu, Ying Bai, Yaoyao Wu, Yun-Gen Xu

European journal of medicinal chemistry

2019

Targeting VEGF-neuropilin interactions: a promising antitumor strategy.

Kewen Peng, Ying Bai, Qi-Hua Zhu, Bin Hu, Yun-Gen Xu

Drug Discovery Today

2019

Half-curcumin analogues as PET imaging probes for amyloid beta species.

Jian Yang, Ran Cheng, Hua-Long Fu, Jing Yang, Mohanraja Kumar, Jie Lu, Yun-Gen Xu, Steven H. Liang, M. Cui, Chong-Zhao Ran

Chemical Communications

2019

Near-infrared Fluorescence Ocular Imaging (NIRFOI) of Alzheimer’s Disease

Jian Yang, Jing Yang, Yu-Yan Li, Yun-Gen Xu, Chong-Zhao Ran

Molecular Imaging and Biology

2019

Identification of New Inhibitors of Mutant Isocitrate Dehydrogenase 2 through Molecular Similarity-based Virtual Screening

Lijun Yang, S. Pusch, V. Jennings, Tianfang Ma, Qi-Hua Zhu, Yun-Gen Xu, A. von Deimling, X. Zha

Letters in Drug Design & Discovery

2019

Highly specific detection of Aβ oligomers in early Alzheimer's disease by a near-infrared fluorescent probe with a "V-shaped" spatial conformation.

Jian Yang, Fan-Tian Zeng, Xiao-Fang Li, Chong-Zhao Ran, Yun-Gen Xu, Yu-Yan Li

Chemical Communications

2019

The development of Near-infrared Fluorescent Probes in Alzheimer's disease.

Jian Yang, Fan-Tian Zeng, Yiran Ge, Kewen Peng, Xiao-Fang Li, Yu-Yan Li, Yun-Gen Xu

Bioconjugate chemistry

2019

A new lysosome-targetable fluorescent probe with a large Stokes shift for detection of endogenous hydrogen polysulfides in living cells.

Yanshen Ren, Lulu Zhang, Zi-Yan Zhou, Yanjun Luo, Sui-Lou Wang, S. Yuan, Yueqing Gu, Yun-Gen Xu, X. Zha

Analytica Chimica Acta

2018

阿片受体激动剂研究进展

朱良瀚,崔芷莹,朱启华,徐云根

《药学进展》

2018

Novel aromatic sulfonyl naphthalene-based boronates as 20S proteasome inhibitors.

Hongwu Liu, Jian-Wei Wu, Yi-yu Ge, Aibo Li, Jia Li, Zheng-Shuang Liu, Yun-Gen Xu, Qing-Xiang Xu, Yu-Yan Li

Bioorganic & Medicinal Chemistry

2018

Inhibitors of Mutant Isocitrate Dehydrogenases 1 and 2 (mIDH1/2): An Update and Perspective.

Tianfang Ma, Fangxia Zou, S. Pusch, Yun-Gen Xu, A. von Deimling, X. Zha

Journal of Medicinal Chemistry

2018

Optimization of 5-arylidene barbiturates as potent, selective, reversible LSD1 inhibitors for the treatment of acute promyelocytic leukemia.

Si-Yuan Xu, Chen Zhou, Rongfeng Liu, Qi-Hua Zhu, Yun-Gen Xu, Fei Lan, X. Zha

Bioorganic & Medicinal Chemistry

2018

A highly sensitive fluorescent probe for selective detection of cysteine/homocysteine from glutathione and its application in living cells and tissues

Zi-Yan Zhou, Guo-Feng Duan, Yingying Wang, Shikui Yang, Xuyang Liu, Liying Zhang, Runing Sun, Yun-Gen Xu, Yueqing Gu, X. Zha

2018

A new fluorescent probe for quick and highly selective detection of hydrogen sulfide and its application in living cells

Yanshen Ren, Lulu Zhang, Zi-Yan Zhou, Sui-Lou Wang, Yun-Gen Xu, Yueqing Gu, X. Zha

2018

Novel Opioid Receptor Agonists with Reduced Morphine-like Side Effects.

Lianghan Zhu, Zhiying Cui, Qi-Hua Zhu, X. Zha, Yun-Gen Xu

Mini-Reviews in Medical Chemistry

2018

Recent advances in inhibitors of sirtuin1/2: an update and perspective.

Zi-Yan Zhou, Tianfang Ma, Qi-Hua Zhu, Yun-Gen Xu, X. Zha

Future Medicinal Chemistry

2018

A novel limonin derivate modulates inflammatory response by suppressing the TLR4/NF-κB signalling pathway.

Shuwei Jin, Jing-Qi Wang, Si-Ying Chen, Aidou Jiang, Mei-Ling Jiang, Yourui Su, Wei Yan, Yun-Gen Xu, Guoqing Gong

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

2018

Design, synthesis and biological activity of 4-(4-benzyloxy)phenoxypiperidines as selective and reversible LSD1 inhibitors.

Jiayue Xi, Si-Yuan Xu, Lulu Zhang, Xueyuan Bi, Yanshen Ren, Yu-Chih Liu, Yueqing Gu, Yun-Gen Xu, Fei Lan, X. Zha

Bioorganic chemistry (Print)

2017

PI3K抑制剂与其他药物联用克服耐药性的研究进展

贾成舒,王均伟,李慧,朱启华,葛亦然,徐云根

《中国药科大学学报》

2017

绿卡色林衍生物的合成、体外代谢及体内活性研究

张灵芝,蒋敏瑞,魏萍,朱启华,龚国清,卞学国,徐云根

《高等学校化学学报》

2017

具有四氢苯并[4,5]咪唑并[1,2-a]吡嗪骨架凝血酶抑制剂的设计合成及生物活性研究

陈东星,施锦渝,陈秋芳,张芮,龚国清,徐云根,朱启华

《高等学校化学学报》

2017

Design, synthesis and biological evaluation of novel 3H-imidazole [4,5-b] pyridine derivatives as selective mTOR inhibitors.

Ling-Zhi Zhang, Tan-Tan Bu, Xiao-Bo Bao, Tingting Liang, Yiran Ge, Yun-Gen Xu, Qi-Hua Zhu

Bioorganic & Medicinal Chemistry Letters

2017

Identification of novel allosteric inhibitors of mutant isocitrate dehydrogenase 1 by cross docking-based virtual screening.

Fangxia Zou, S. Pusch, J. Hua, Tianfang Ma, Lijun Yang, Qi-Hua Zhu, Yun-Gen Xu, Yueqing Gu, A. von Deimling, X. Zha

Bioorganic & Medicinal Chemistry Letters

2017

Design, synthesis and antithrombotic evaluation of novel non-peptide thrombin inhibitors.

Dong-Xing Chen, Jin-Yu Shi, Jing Liu, Xueying Zhang, Xiao-Ying Deng, Yan-Yan Yang, Shuang Cui, Qi-Hua Zhu, Guoqing Gong, Yun-Gen Xu

Bioorganic & Medicinal Chemistry

2017

Design, synthesis and biological activity of 3-pyrazine-2-yl-oxazolidin-2-ones as novel, potent and selective inhibitors of mutant isocitrate dehydrogenase 1.

Tianfang Ma, Fangxia Zou, S. Pusch, Lijun Yang, Qi-Hua Zhu, Yun-Gen Xu, Yueqing Gu, A. von Deimling, X. Zha

Bioorganic & Medicinal Chemistry

2017

Copper(I) and N-fluorobenzenesulfonimide-mediated direct regioselective halogenation of 8-amidoquinolines on the C5 position

Xin He, Yizhu Xu, Ling-xuan Kong, Huanhuan Wu, De-Zhong Ji, Zhibin Wang, Yun-Gen Xu, Qi-Hua Zhu

2017

Pathological Role of Peptidyl-Prolyl Isomerase Pin1 in the Disruption of Synaptic Plasticity in Alzheimer's Disease

Lingyan Xu, Zhi-Yun Ren, Frances E. Chow, Richard M. Tsai, Tongzheng Liu, F. Rizzolio, S. Boffo, Yun-Gen Xu, Shao-Hui Huang, C. Lippa, Yuesong Gong

Journal of Neural Transplantation and Plasticity

2017

Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors.

Yi-yu Ge, Aibo Li, Jian-Wei Wu, Hai-wei Feng, Letian Wang, Hongwu Liu, Yun-Gen Xu, Qing-Xiang Xu, Li Zhao, Yu-Yan Li

European journal of medicinal chemistry

2017

VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012-2016)

Fan-Wei Peng, Da-Ke Liu, Qing-Wen Zhang, Yun-Gen Xu, Lei Shi

Expert Opinion on Therapeutic Patents

2017

Targeting β-amyloid plaques and oligomers: development of near-IR fluorescence imaging probes.

Hongwu Liu, Jian Yang, Letian Wang, Yun-Gen Xu, Siyuan Zhang, Jie Lv, Chong-Zhao Ran, Yu-Yan Li

Future Medicinal Chemistry

2017

Design and discovery of 4-anilinoquinazoline-urea derivatives as dual TK inhibitors of EGFR and VEGFR-2.

Hai-Qi Zhang, Fei-Hu Gong, Ji-Qing Ye, Chi Zhang, Xiao-Hong Yue, Chuan-Gui Li, Yun-Gen Xu, Li-Ping Sun

European journal of medicinal chemistry

2017

Design, synthesis and biological evaluation of aminobenzyloxyarylamide derivatives as selective κ opioid receptor antagonists.

Jun-Wei Wang, Qiao Song, Anhua Xu, Yu Bao, Yun-Gen Xu, Qi-Hua Zhu

European journal of medicinal chemistry

2017

Oxalate-curcumin–based probe for micro- and macroimaging of reactive oxygen species in Alzheimer’s disease

Jian Yang, Xueli Zhang, Peng Yuan, Jing Yang, Yun-Gen Xu, J. Grutzendler, Yihan Shao, A. Moore, Chong-Zhao Ran

Proceedings of the National Academy of Sciences of the United States of America

2016

减肥药的研究进展

张灵芝,朱启华,徐云根

《中国新药杂志》

2016

盐酸氯卡色林的合成研究进展

贺新,王均伟,朱启华,徐云根

《中国新药杂志》

2016

BCR-ABL激酶抑制剂的研究进展

李琳毅,徐云根

《中国现代应用药学》

2016

可逆型质子泵抑制剂最新研究进展

黄群刚,朱启华,徐云根

《药学进展》

2016

奥拉帕尼合成路线图解

张广霞,朱启华,徐云根

《中国医药工业杂志》

2016

Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography.

X. Zha, D. Lamba, Li-Li Zhang, Yinghan Lou, Changxu Xu, Di Kang, Li Chen, Yun-Gen Xu, Lu-Yong Zhang, A. De Simone, Sarah Samez, A. Pesaresi, J. Stojan, Manuela G. López, J. Egea, V. Andrisano, M. Bartolini

Journal of Medicinal Chemistry

2016

Design, synthesis and biological evaluation of novel 5-fluoro-1H-benzimidazole-4-carboxamide derivatives as potent PARP-1 inhibitors.

Jun-Wei Wang, Xuyan Wang, Hui Li, De-Zhong Ji, Yu-Yan Li, Yun-Gen Xu, Qi-Hua Zhu

Bioorganic & Medicinal Chemistry Letters

2016

Design, synthesis and biological evaluation of novel tetrahydroisoquinoline quaternary derivatives as peripheral κ-opioid receptor agonists.

Ting Guo, Zong-Jie Gan, Jie Chen, De-Chuan Wang, Ling He, Qiao Song, Yun-Gen Xu

Bioorganic & Medicinal Chemistry

2016

Novel tricyclic poly (ADP-ribose) polymerase-1/2 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis and biological evaluation.

Hui Li, Yan Hu, Xueyan Wang, Guang-Wei He, Yun-Gen Xu, Qi-Hua Zhu

Bioorganic & Medicinal Chemistry

2016

塩酸LvKa色林の合成研究の進展【JST・京大機械翻訳】

Xin He, Jun-Wei Wang, Qi-Hua Zhu, Yun-Gen Xu

2016

Progress in synthesis of lorcaserin hydrochloride

Xin He, Jun-Wei Wang, Qi-Hua Zhu, Yun-Gen Xu

2016

Metal-Free Remote C-H Bond Amidation of 8-Amidoquinolines on the C5 Position under Mild Conditions.

De-Zhong Ji, Xin He, Yizhu Xu, Ziyue Xu, Yuchen Bian, Weixing Liu, Qi-Hua Zhu, Yun-Gen Xu

Organic Letters

2016

Correction to "Metal-Free Remote C-H Bond Amidation of 8-amidoquinolines on the C5 Position under Mild Conditions".

De-Zhong Ji, Xin He, Yizhu Xu, Ziyue Xu, Yuchen Bian, Weixing Liu, Qi-Hua Zhu, Yun-Gen Xu

Organic Letters

2016

Effect of CPU-XT-008, a combretastatin A-4 analogue, on the proliferation, apoptosis and expression of vascular endothelial growth factor and basic fibroblast growth factor in human umbilical vein endothelial cells.

Rui Xiong, Jing Sun, Kun Liu, Yun-Gen Xu, Shu-fen He

Oncology Letters

2016

奥拉Pa尼合成ルート図解【JST・京大機械翻訳】

Guang-Xia Zhang, Qi-Hua Zhu, Yun-Gen Xu

2016

Palladium-Catalyzed Synthesis of Novel O-Heterocycles by Domino Suzuki Coupling-Michael Addition Reaction

Qi-Hua Zhu, Feng Nie, Jingjie Feng, Yu-Yan Li, Xuyan Wang, Yun-Gen Xu

2016

Imaging hydrogen peroxide in Alzheimer’s disease via cascade signal amplification

Jian Yang, Jing Yang, Steven H. Liang, Yun-Gen Xu, A. Moore, Chong-Zhao Ran

Scientific Reports

2016

O1‐12‐04: Near Infrared Fluorescence Imaging of Reactive Oxygen Species in Alzheimer’s Disease Via Transformation From “Visible” to “Invisible”

Chong-Zhao Ran, Jing Yang, Jian Yang, Peng Yuan, J. Grutzendler, Yun-Gen Xu

2016

Identification of a novel selective inhibitor of mutant isocitrate dehydrogenase 1 at allosteric site by docking-based virtual screening

Fangxia Zou, S. Pusch, J. Eisel, Tianfang Ma, Qi-Hua Zhu, Da-Wei Deng, Yueqing Gu, Yun-Gen Xu, A. von Deimling, X. Zha

2015

Combretastatin A-4氨基糖类衍生物CPU-XT-008抑制血管内皮细胞增殖的分子机制

何书英,熊蕊,刘坤,徐云根

《中国药科大学学报》

2015

尼达尼布的合成

贾本立,朱雄,陈仁杰,袁铎,徐云根

《合成化学》

2015

柠檬苦素类似物的生物活性和构效关系研究进展

韩学青,朱启华,王少驰,徐云根

《药学进展》

2015

Corrigendum to "Discovery of quinazolin-4-amines bearing benzimidazole fragments as dual inhibitors of c-Met and VEGFR-2" [Bioorg. Med. Chem. 22 (2014) 4735-4744].

Lei Shi, Ting-Ting Wu, Zhi Wang, Jia‐Yu Xue, Yun-Gen Xu

Bioorganic & Medicinal Chemistry

2015

Design, synthesis and antithrombotic evaluation of novel dabigatran etexilate analogs, a new series of non-peptides thrombin inhibitors.

Dong-Xing Chen, Shao-Chi Wang, Xiao-Juan Diao, Qi-Hua Zhu, Hui Shen, Xue-Qing Han, Yiwei Wang, Guoqing Gong, Yun-Gen Xu

Bioorganic & Medicinal Chemistry

2015

Discovery and SAR study of 2-(1-propylpiperidin-4-yl)-3H-imidazo[4,5-c]pyridine-7-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase-1 (PARP-1) for the treatment of cancer.

Qi-Hua Zhu, Xueyan Wang, Yan Hu, Xiao-Rong He, Guoqing Gong, Yun-Gen Xu

Bioorganic & Medicinal Chemistry

2015

Fluorescent Coumarin-Artemisinin Conjugates as Mitochondria-Targeting Theranostic Probes for Enhanced Anticancer Activities.

Xu Zhang, Qian Ba, Zhan-Ni Gu, Diliang Guo, Yu Zhou, Yun-Gen Xu, Hui Wang, Deju Ye, Hong Liu

Chemistry

2015

Synthesis and biological evaluation of novel laropiprant derivatives as potential anti-allergic agents

Hai-Ping Zhou, Qi-Hua Zhu, Zongjie Gan, Guang-Ping Dong, Yun-Gen Xu

Medicinal Chemistry Research

2015

Identification of new non-steroidal TGR5 agonists using virtual screening with combined pharmacophore models

Chen Zhou, Fangxia Zou, Yun-Gen Xu, Luyong Zhang, X. Zha

Medicinal Chemistry Research

2015

Efficient Palladium-Catalyzed C—H Fluorination of C(sp3)—H Bonds: Synthesis of β-Fluorinated Carboxylic Acids.

Qi-Hua Zhu, De-Zhong Ji, Tingting Liang, Xueyan Wang, Yun-Gen Xu

2015

A class of derivatives of ca-4, their preparation, and pharmaceutical use

Yun-Gen Xu, Kun Liu, Xiao-Hang Song, Hong-Zhuo Chen, Hong-Bo Zhang, Ling-Zhi Zhang, Qi-Hua Zhu

2015

Synthesis of 6-Substituted Phenanthridine Derivatives by Palladium-Catalyzed Domino Suzuki—Miyaura/Aza-Michael Reactions.

Xiao-Bo Bao, Wei Yao, Qi-Hua Zhu, Yun-Gen Xu

2015

Novel Synthesis of Antiobesity Drug Lorcaserin Hydrochloride

Qi-Hua Zhu, Jun-Wei Wang, Xue Bian, Ling-Zhi Zhang, P. Wei, Yun-Gen Xu

2015

Design, Synthesis, and Biological Evaluation of Dabigatran Etexilate Mimics, a Novel Class of Thrombin Inhibitors

Shao-Chi Wang, Peng Dai, Yun-Gen Xu, Qiu-Fang Chen, Qi-Hua Zhu, Guoqing Gong

Archiv der Pharmazie

2015

Identification of Novel Selective Lysine‐Specific Demethylase 1 (LSD1) Inhibitors Using a Pharmacophore‐Based Virtual Screening Combined with Docking

Chen Zhou, Di Kang, Yun-Gen Xu, Lu-Yong Zhang, X. Zha

Chemical Biology and Drug Design

2014

Synthesis and pharmacological evaluation of novel limonin derivatives as anti-inflammatory and analgesic agents with high water solubility.

Yung-Hsiung Yang, Xin-Hui Wang, Qi-Hua Zhu, Guoqing Gong, D. Luo, Aidou Jiang, Li-Yan Yang, Yun-Gen Xu

Bioorganic & Medicinal Chemistry Letters

2014

Development and validation of a liquid chromatography/tandem mass spectrometry assay for the simultaneous determination of dabigatran etexilate, intermediate metabolite and dabigatran in 50μL rat plasma and its application to pharmacokinetic study.

Jin-Yin Li, Jing Fang, Fanyi Zhong, Wen-Xue Li, Yuan-Jun Tang, Yun-Gen Xu, Shilong Mao, Guorong Fan

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

2014

Synthesis of 6-Substituted Phenanthridine Derivatives by Palladium-Catalysed Domino Suzuki–Miyaura/Aza-Michael Reactions

Xiao-Bo Bao, Wei Yao, Qi-Hua Zhu, Yun-Gen Xu

2014

Synthesis Process of Cinacalcet Hydrochloride

Xue Bian, Jun-Wei Wang, Qi-Hua Zhu, Yun-Gen Xu

2014

p-Toluenesulfonohydrazide as highly efficient initiator for direct C-H arylation of unactivated arenes.

Qiao Song, Dongmei Zhang, Qi-Hua Zhu, Yun-Gen Xu

Organic Letters

2014

Design, Synthesis and Anti-Allergic Activity Evaluation of Aryl-Acetic Acid Derivatives

Haipin Zhou, Yu‐Mei Jin, Xue Bian, Qi-Hua Zhu, Guang-Ping Dong, Yun-Gen Xu

2013

考布他汀A-4衍生物CPU-XT-006对人脐静脉内皮细胞增殖、凋亡及VEGF、bFGF表达的影响

何书英,孙菁,刘坤,徐云根

《中国药科大学学报》

2013

蒽环类抗肿瘤化合物的研究进展

韩崇,朱雄,徐云根

《中国新药杂志》

2013

Design, synthesis and biological evaluation of novel imidazo[4,5-c]pyridinecarboxamide derivatives as PARP-1 inhibitors.

Qi-Hua Zhu, Xuyan Wang, Zhao-Xing Chu, Guang-Wei He, Guang-Ping Dong, Yun-Gen Xu

Bioorganic & Medicinal Chemistry Letters

2013

Design, synthesis and biological evaluation of novel 4-anilinoquinazolines with C-6 urea-linked side chains as inhibitors of the epidermal growth factor receptor.

Xu Zhang, Ting Peng, Xun Ji, Jian Li, Lin-jiang Tong, Zeng Li, Wei Yang, Yun-Gen Xu, Meng-yuan Li, Jian Ding, Hua-Liang Jiang, Hua Xie, Hong Liu

Bioorganic & Medicinal Chemistry

2013

Synthesis and anti-angiogenetic activity evaluation of N-(3-aryl acryloyl)aminosaccharide derivatives.

Kun Liu, Shuo-Wei Yao, Yinghan Lou, Yun-Gen Xu

Carbohydrate Research

2013

2-[(4-cyano-benzyl)amino]ethyl acetate hydrochloride preparation method

Yun-Gen Xu, Peng Dai, Qi-Hua Zhu, Liang Li

2013

An efficient procedure for synthesis of 2, 3-dihydro-1H-indene-1-methanamines

Haipin Zhou, Hui-Chi Su, Zong-Jie Gan, De-Chuan Wang, Yun-Gen Xu

Research on chemical intermediates (Print)

2013

Recent progress in research on anthracyclines

Yun-Gen Xu

2013

Design, Synthesis and Biological Evaluation of Novel Aminosaccharide Derivatives of Combretastatin A-4

Yan-Boi Tang, Zhewei Tu, Jing Sun, Xiong Zhu, Kun Liu, Shu-fen He, Yun-Gen Xu

2012

来那度胺及其氨基糖偶联物的合成及抗肿瘤血管生成活性

刘坤,董缙,孙菁,储昭兴,何书英,徐云根

《中国药科大学学报》

2012

对叠氮-L-苯丙氨酸盐酸盐的合成及其在重组人内皮抑素中的定点引入

郭林峰,徐云根,田浤,刘静娴,姚文兵

《中国药科大学学报》

2012

4(6)-{2-[4-(2,3,4-三甲氧基苄基)哌嗪-1-基]-2-氧代乙氧基}芳甲酰胍类化合物的合成及其Na+/H+交换器1抑制活性

靳璐,姜向敏,何广卫,徐文婷,龚国清,徐云根

《有机化学》

2012

来源于天然产物的乙酰胆碱酯酶抑制剂研究进展

楼影涵,査晓明,张莉莉,张茵,徐云根,张陆勇

《药学进展》

2012

Palladium-Catalyzed Tandem Reactions of β-(2-Bromophenyl)-α,β-Unsaturated Carbonyl Compounds with 2-Hydroxyphenylboronic Acid: A New Route to Benzo[c]chromenes.

Qi-Hua Zhu, Xuyan Wang, Yun-Gen Xu

2012

Convenient Chlorination of Some Special Aromatic Compounds Using N‐Chlorosuccinimide.

Zong-Jie Gan, Bin Hu, Qiao Song, Yun-Gen Xu

2012

Scale-Up Synthesis of Antidepressant Drug Vilazodone

Bin Hu, Qiao Song, Yun-Gen Xu

2011

茚喹诺啉对映体的手性拆分及转化研究

孙德助,杭太俊,宋敏,于晓蓉,侯春燕,韩睿,孙春萌,涂家生,甘宗捷,张迪,徐云根

《药物分析杂志》

2011

取代苯甲酰胍与曲美他嗪偶联物的合成及对Na+/H+交换器-1的抑制活性

杜萍,张迪,张国敏,任淑娟,龚国清,徐云根

《中国药科大学学报》

2011

细胞毒药物与肿瘤血管生成

屠哲玮,陶一飞,董缙,徐云根

《中国现代应用药学》

2011

阿魏酰胍丁胺类似物的设计、合成及Na+/H+交换器-1抑制活性

李家明,何勇,周鹏,徐云根,彭家志,盛日正

《药学学报》

2011

Silver-Catalyzed Intramolecular Hydroamination of Alkynes in Aqueous Media: Efficient and Regioselective Synthesis for Fused Benzimidazoles.

Xu Zhang, Yu Zhou, Hengshuai Wang, Diliang Guo, Deju Ye, Yun-Gen Xu, Hua-Liang Jiang, Hong Liu

2011

An Improved Synthesis of Substituted Indan‐1‐carboxylic Acid.

Zong-Jie Gan, Di Zhang, Zhe Cao, Yun-Gen Xu

2011

Study on chiral separation and transformation of indiquinoline enantiomers

Yun-Gen Xu

2011

An Effective Synthetic Entry to Fused Benzimidazoles via Iodocyclization

Xu Zhang, Yu Zhou, Hengshuai Wang, Diliang Guo, Deju Ye, Yun-Gen Xu, Hua-Liang Jiang, Hong Liu

2011

Synthesis of N-Heteroaryl Aminosaccharide Derivatives as Fibroblast Growth Factor 2 Signaling Modulators.

Jinjiao Dong, Shuo-Wei Yao, Xiao-yan Zhou, Lijuan Zhang, Yun-Gen Xu

2010

Synthesis of N-heteroaroyl aminosaccharide derivatives as fibroblast growth factor 2 signaling modulators.

Jinjiao Dong, Shuo-Wei Yao, Xiao-yan Zhou, Lijuan Zhang, Yun-Gen Xu

Chemical and pharmaceutical bulletin

2009

Synthesis and Na+/H+ Exchanger‐1 Inhibitory Activity of Substituted (Quinolinecarbonyl)guanidine Derivatives

Dan Mao, Yun-Gen Xu, Xiao-Ping P. Hu, Guo-Min Zhang, Jinjiao Dong, Guoqing Gong

Chemistry and Biodiversity

2008

A Review of Immunosuppressant FTY720 and its Analogs

Yun-Gen Xu

2007

2-[5-取代苯并咪(噻)唑-2-硫基]-1-(4-取代苯基)乙酮缩氨基胍的合成及NHE1抑制活性

姚硕蔚,张睿,徐云根,华维一,文娜

《中国药物化学杂志》

2007

N-[4-(苯并咪唑-2-硫基)苯基]-N′-烷基胍类衍生物的合成和生物活性

徐云根,邢爱敏,洪敏,孙晓玉

《药学学报》

2007

达泊西汀的合成进展

张飞皇,陈弢,徐云根

《中国新药杂志》

2006

1-烷基-3-[4-(苯并噻唑-2-巯基)苯基]胍类化合物的合成及其生物活性

邢爱敏,徐云根,洪敏,孙晓玉

《中国药科大学学报》

2006

2-芳亚胺基-4-噻唑烷酮类化合物的合成及生物活性

张大永,向华,徐云根,华维一

《药学学报》

2006

卡立泊来德的合成工艺改进

金宁,徐云根,华维一

《中国药物化学杂志》

2005

Na+/H+交换器抑制剂研究进展

雷林,徐云根,华维一

《中国药学杂志》

2004

4-(苯并咪(噻)唑2-)苯甲脒类化合物的合成及其一氧化氮合酶抑制活性

王新图,徐云根,华维一,奚涛

《中国药科大学学报》

2004

烟拉文的合成工艺改进

邢爱敏,张睿,徐云根

《中国药物化学杂志》

2004

抗肿瘤药泰克地那林的合成工艺改进

徐云根,辜正一,华维一

《中国药物化学杂志》

2004

1-烃基(或氢)-3-[4-(5-取代苯并咪(噻)唑-2-巯基)苯基]硫脲的合成及其iNOS抑制活性

徐云根,罗穗,华维一,朱东亚

《中国药科大学学报》

2003

四氢异喹啉衍生的硫脲和异硫脲化合物的合成及NOS抑制活性研究Ⅰ.

张大永,徐云根,华维一,奚涛

《中国药科大学学报》

2002

盐酸洛美利嗪的NMR研究

张尊建,李茜,沈文斌,徐云根

《中国药科大学学报》

2002

HPLC法测定西尼地平及其片剂的含量

沈卫阳,杜迎翔,黄驰,徐云根

《中国药科大学学报》

2001

高效液相色谱法测定利塞膦酸钠片的含量

郝卫强,刘文英,狄斌,徐云根

《中国药科大学学报》

2001

氨氯地平衍生物的合成和降血压活性研究

徐云根,陈钟,杨幼瑶,华维一,江振洲

《中国药科大学学报》

2000

5,6-二甲氧基-1-吲酮的合成

徐云根,华维一,张敬新

《中国现代应用药学》

2000

盐酸西布曲明的合成

徐云根,罗穗,华维一

《中国现代应用药学》

1999

醋氯酚酸原料含量测定方法的研究

赵金会,徐云根,陈玉英

《中国药科大学学报》

1997

头孢哌酮合成工艺的改进

徐云根,吉民,华维一

《中国药科大学学报》

1997

催眠药替马西泮的合成

吉民,徐云根,张惠敏,熊文南,华维一

《中国药科大学学报》

1996

吡拉西坦的一步合成新方法

徐云根,杨春,华维一

《中国药科大学学报》

1991

3-取代二碘苯甲酰吲哚衍生物的合成

徐云根,彭司勋,黄枕亚

《中国药科大学学报》

会议论文

2018

Design,synthesis and biological evaluation of limonin derivatives

梁停停,贾成舒,朱启华,徐云根

《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》

2018

Design,synthesis and biological evaluation of novel μ-opioid receptor agonists

朱良瀚,崔芷莹,朱启华,徐云根

《第11届世界华人药物化学研讨会(ISCMC 2018)论文摘要集》

2018

Discovery of IDO1/IDO2 dual inhibitors with high antitumor efficiency:design,synthesis,and preliminary mechanism exploration

Xin He, Guangchao He, Qiha Zhu, Junjie Wang, Yungen Xu

《第11届世界华人药物化学研讨会(ISCMC 2018)》

2012

来那度胺及其氨基糖偶联物的合成与生物活性研究

刘坤,董缙,孙菁,何书英,徐云根

《2012长三角药物化学研讨会论文集》

2012

PARP-1抑制剂的设计,合成及生物活性研究

王旭艳,朱启华,朱虹,何俏军,徐云根

《2012长三角药物化学研讨会论文集》

2012

An Efficient Synthesis of Antidepressant Drug Vilazodone

Bin Hu, Cuitian Chen, Yungen Xu

《2012长三角药物化学研讨会》

2011

DP1受体拮抗剂拉罗匹仑的合成工艺研究

周海平,姚魏,徐云根

《2011年全国药物化学学术会议——药物的源头创新论文摘要集》

2011

Design and Synthesis of Novel Derivatives of Dabigatran Based-on Scaffold Hopping

杨小治,刁小娟,龚国清,徐云根

《2011年全国药物化学学术会议——药物的源头创新》

此主页由公开资料整理,尚未经学者本人认领。